Chinese Bio

Jerry is a patent attorney and concentrates his practice mainly in intellectual property, corporate and litigation matters.

With an M.S. in polymer science, a Ph.D. in organic chemistry and substantial industrial experiences in both U.S. and China, Jerry has experience in all areas of intellectual property law with a focus on chemistry, pharmaceutical, biotech, material sciences and medical device-related inventions and FDA law and regulations. He helps individual and institutional clients from both the U.S. and China in pharmaceutical, cosmetic, chemical and biotech, as well as other industries on their matters in various areas of law.

He counsels clients regarding their IP strategies, global IP rights protection and drug development strategies. 

  • Advise on patent protection strategies and draft and prosecute patent applications globally
  • Advise on trademark registration strategies and apply for trademark registrations globally
  • Provide patentability, non-infringement, invalidity and freedom-to-operate analysis and opinions
  • Conduct IP due diligence for investment, corporate mergers and acquisitions, technology transfer or licensing, etc.
  • Advise on new drug development strategies and abbreviated new drug application (ANDA) processes

He assists clients in corporate and litigation matters.

  • Advise on business entity selections and help with formation of U.S. companies or subsidiaries  
  • Prepare and negotiate business contracts, such as service contracts, collaboration contracts, clinical trial contracts, joint venture agreements and technology transfer or license agreements, etc.
  • Advise on corporate structuring, shareholder agreement and private equity transfers, etc.
  • Help evaluate and resolve commercial or IP disputes and provide technical and legal analysis in complex patent/trade secret litigations, in particular Hatch-Waxman patent litigations

Jerry serves as the chair of Fox Rothschild's firmwide China Practice Group. 

Before Fox Rothschild

Upon obtaining a B.S. degree in chemistry and an M.S. degree in polymer science and before coming to the U.S., Jerry worked as an assistant engineer in the technology development department of Yizheng Chemical Fibre Co., Ltd., now a subsidiary of Sinopec, of China.

Upon obtaining his Ph.D. degree in organic chemistry with Prof. Sir Derek H. R. Barton (Nobel Prize, 1969) at Texas A&M University, Jerry worked as a postdoctoral research associate with Prof. Lanny S. Liebeskind at Emory University for over two years and then worked as a research investigator/senior research investigator in the pharmaceutical development division of Bristol-Myers Squibb Company for several years. His research experience includes organic synthesis, radical chemistry, organometallics, transition metal-catalyzed reactions, heterocycles, polymers, and biomedical materials, in particular pharmaceutical process research and development and scale-up of processes in glass plants and pilot plants under the FDA’s cGMP guidelines.

In law school, Jerry participated in the Community Law Clinic and served as a Facilitator in the Minority Student Program tutoring the first-year law students in the Criminal Law class. He was also active in the Rutgers Intellectual Property Law Society and Rutgers International Law Society. Jerry joined Fox Rothschild as a Summer Associate in summer 2007 and then worked as a part time law clerk for one year before becoming a full-time associate with the firm in 2008.

Beyond Fox Rothschild

Jerry is involved in numerous community activities, serving as a volunteer in various charitable nonprofit organizations, and has provided pro bono legal services to indigent clients through the firm’s pro bono programs. He is currently president of the Sino-American Pharmaceutical Professionals Association (SAPA), co-chair of the CNIPA (China National Intellectual Property Administration) Committee of the New York Intellectual Property Law Association (NYIPLA), and general counsel for the University of Science and Technology of China Alumni Association of Greater New York (USTCAAGNY). Jerry has served as the director of SAPA's Scholarship Department  (2010-2018); a member of the Board of Trustees of the Huaxia Edison Chinese School (2010-2012, Chairman of the Board from 2011-2012); and as a member of the Board of Directors of Huaxia Chinese School (2011-2012).


Patents & Patent Applications

Method of Preparation of Azaindole Derivatives
Inventors: Liu, W.; Patel, S. S.; Cuniere, N.; Lear, Y.; Deshpande, P.; Simon, J. N.; Lai, C.; Pullockaran, A. J.; Soundararajan, N.; Bien, J.
U.S. Patent No. 7,820,820
October 26, 2010

Method of Preparation of Azaindole Derivatives
Inventors: Liu, W.; Patel, S. S.; Cuniere, N.; Lear, Y.; Deshpande, P.; Simon, J. N.; Lai, C.; Pullockaran, A. J.; Soundararajan, N.; Bien, J.
U.S. Patent No. 7,598,380
October 6, 2009

Process for Removing Metals from Liquids
Inventor: Liu, W.
U.S. Patent No. 7,300,639
November 27, 2007

Synthesis of 4-Substituted Pyrrole-2-Carboaldehyde Compounds
Inventors: Liebeskind, L. S.; Liu, W.
U.S. Patent No. 6,441,194
August 27, 2002

Honors & Awards

  • Awarded the Yilida Prize as an undergraduate from Univ. of Sci. & Tech. of China (1986)
  • During graduate school at Univ. of Sci. & Tech. of China, Jerry obtained the Excellent M.S. Thesis Award. (1990)
  • At Texas A&M Univ., Jerry was a member of Phi Lambda Upsilon Honor Society. (1993)
  • During law school, he served as the Editor-in-Chief of the Rutgers Law Record (2007-2008) and also served on the editorial boards of the Rutgers Business Law Journal (Business Editor, 2006-2007) and the Rutgers Conflict Resolution Law Journal (On-line Editor, 2006-2007).